Clinical trial
In Vivo Intravascular Diagnostics and Evaluation of New Therapeutic Modalities in Systemic Autoimmune and Coronary Artery Disease Patients
NCT02510092 is registered in ClinicalTrials.gov with Semmelweis University Heart and Vascular Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- In Vivo Intravascular Diagnostics and Evaluation of New Therapeutic Modalities in Systemic Autoimmune and Coronary Artery Disease Patients
- Lead sponsor
- Semmelweis University Heart and Vascular Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- March 31, 2021
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.